Skip to main content
  • AACR Publications
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

  • Register
  • Log in
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Focus on Computer Resources
    • 75th Anniversary
    • Meeting Abstracts
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citations
    • Author/Keyword
  • News
    • Cancer Discovery News
  • AACR Publications
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in

Search

  • Advanced search
Cancer Research
Cancer Research

Advanced Search

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Focus on Computer Resources
    • 75th Anniversary
    • Meeting Abstracts
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citations
    • Author/Keyword
  • News
    • Cancer Discovery News
Prevention Research

Abstract #4818: IGF-II leads to estrogen receptor phosphorylation via IGF-IR and IR activity

Angelique Ellerbee-Richardson, Nalo Hamilton and Daisy De Leon
Angelique Ellerbee-Richardson
Loma Linda Univ. School of Medicine, Loma Linda, CA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nalo Hamilton
Loma Linda Univ. School of Medicine, Loma Linda, CA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daisy De Leon
Loma Linda Univ. School of Medicine, Loma Linda, CA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI:  Published May 2009
  • Article
  • Info & Metrics
Loading
AACR Annual Meeting-- Apr 18-22, 2009; Denver, CO

Abstract

Estrogen receptor negative (ER-) tumors are more common in African American (AA) women, when compared to Caucasian women (C). These aggressive tumors are more common at every age and stage of breast cancer and are responsible for the survival disparity observed among AA patients. Thus, our laboratory is investigating how IGF-II activates estrogen receptors without the requirement of estrogen in breast cancer cells derived from breast tumors from AA patients and compared to cells derived from C patients. IGF-II is a fetal growth factor regulated by estrogen that promotes proliferation, prevent apoptosis and regulate energy production by signaling through the IGF-I (IGF-IR) and the Insulin Receptors (IR). We previously demonstrated that IGF-II expression in MCF-7 cells promoted tumor growth and metastasis in nude and SCID mice without estrogen treatment. We also demonstrated that IGF-II activated \#8220;estrogen-regulated genes\#8221; in breast cancer cells grown in serum-free media to promote survival and to prevent mitochondrial membrane depolarization. Our hypothesis is that IGF-II mediates estrogen actions in these cells by phosphorylating/activating ER-\#913; and ER- \#914; to promote estrogen independent growth and control mitochondrial and nuclear function to provide energy and cell survival proteins. In our present study we used two ATCC designated ER- breast cancer cell lines: (CRL-2335) a cell line derived from a tumor obtained from an AA (ER-/PR-) and a cell line from C (HS578t) ER-/PR-. We evaluated the phosphorylation and subcellular localization of ER-\#913; and ER-\#914; using Real-time Polymerase Chain Reaction (RT-PCR) and western blot (WB) analysis. The effects of IGF-II on breast cancer cell survival and proliferation were analyzed using MTT assay. The ability of IGF-II to phosphorylate ER-\#913; and ER- \#914; through the IGF-IR and IR was analyzed using IR and IGF-IR siRNA. Since both cell lines secrete high levels of IGF-II, we also used IGF-II siRNA to evaluate the \#8220;basal phosphorylation\#8221; levels of ER-\#913; and ER- \#914;. Our results show that breast cancer cells designated \#8220;ER-\#913; negative\#8221; express significant levels of ER-\#913; and ER- \#914; in the plasma membrane and in the mitochondria. Furthermore, ER-\#913; and ER-\#914; are phosphorylated and translocate within cell compartments when treated with IGF-II. Inhibition of IGF-II by siRNA significantly reduced the \#8220;basal phosphorylation\#8221; of ER- \#913; and ER- \#914;. Thus, our study demonstrates that IGF-II binding to the IGF-IR and IR leads to the phosphorylation of ER- \#913; and ER- \#914;. Since ER- tumors from AA patients express significantly higher levels of IGF-II, our data supports our hypothesis that IGF-II contributes to the survival disparity observed among AA. This may lead to new treatments to reduce the mortality rates and eliminate the survival disparity observed among AA breast cancer patients.

Citation Information: In: Proc Am Assoc Cancer Res; 2009 Apr 18-22; Denver, CO. Philadelphia (PA): AACR; 2009. Abstract nr 4818.

Footnotes

  • 100th AACR Annual Meeting-- Apr 18-22, 2009; Denver, CO

  • American Association for Cancer Research
Back to top
Cancer Research: 69 (9 Supplement)
May 2009
Volume 69, Issue 9 Supplement
  • Table of Contents
  • Index by Author

Sign up for alerts

Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Abstract #4818: IGF-II leads to estrogen receptor phosphorylation via IGF-IR and IR activity
(Your Name) has forwarded a page to you from Cancer Research
(Your Name) thought you would be interested in this article in Cancer Research.
Citation Tools
Abstract #4818: IGF-II leads to estrogen receptor phosphorylation via IGF-IR and IR activity
Angelique Ellerbee-Richardson, Nalo Hamilton and Daisy De Leon
Cancer Res May 1 2009 (69) (9 Supplement) 4818;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Abstract #4818: IGF-II leads to estrogen receptor phosphorylation via IGF-IR and IR activity
Angelique Ellerbee-Richardson, Nalo Hamilton and Daisy De Leon
Cancer Res May 1 2009 (69) (9 Supplement) 4818;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
Advertisement

Related Articles

Cited By...

More in this TOC Section

Prevention Research

  • Abstract LB-153: Lotus leaf and Cassia seed extracts, through activating Nrf2 pathway, suppress TPA-induced mouse skin cell transformation
  • Abstract LB-174: Patient navigation in Appalachia: results from a survey of current practices
  • Abstract LB-167: A novel metabolite of citrus tangeretin epigenetically inhibits the growth of human prostate cancer cells
Show more 3

Behavioral and Social Science in Cancer Prevention and Research -- Poster Presentations - Proffered Abstracts

  • Abstract #4824: Pathologic findings following false positive CA-125 or transvaginal ultrasound screens for ovarian cancer in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial
  • Abstract #4814: Estrogen metabolism in premenopausal women randomized to caloric restriction alone or in combination with aerobic or resistance training
  • Abstract #4821: Prevalence and correlates of indoor tanning among men and women in the United States
Show more 3
  • Home
  • Alerts
  • Feedback
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians
  • Reviewers

About Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2018 by the American Association for Cancer Research.

Cancer Research Online ISSN: 1538-7445
Cancer Research Print ISSN: 0008-5472
Journal of Cancer Research ISSN: 0099-7013
American Journal of Cancer ISSN: 0099-7374

Advertisement